Latest News in the pharma Industry

Top Stories

Jardiance is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Jardiance is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

18 Sep 2015

Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company's Jardiance (empagliflozin) significantly reduced the risk of the combined endpoint of cardiovascular (CV) death, non-fatal heart attack or non-fatal stroke by 14% when added to standard of...

Read more 
CPhI expert warns without urgent regulatory change improving quality is a fool’s game

CPhI expert warns without urgent regulatory change improving quality is a fool’s game

18 Sep 2015

Girish Malhotra believes the pharmaceutical industry should be allowed to commercialise process improvements without regulatory re-approval.

Read more 
Piramal encourages pharma to embrace green chemistry ahead of CPhI

Piramal encourages pharma to embrace green chemistry ahead of CPhI

18 Sep 2015

Processes improvements for original patented products need to be considered, as do improvements beyond even DMF and ANDA submission.

Read more 
The new age of regenerative medicine: why stem cell therapy?

The new age of regenerative medicine: why stem cell therapy?

18 Sep 2015

Frost & Sullivan webinar reveals stem cell therapy pipeline and treatments innovating regenerative medicine.

Read more 
Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

Victoza (liraglutide) provides significantly greater HbA1c reduction than lixisenatide in new clinical trial

17 Sep 2015

Findings from a head-to-head trial comparing Victoza (liraglutide) and lixisenatide, both in combination with metformin, demonstrated a significantly greater reduction in HbA1c of -1.83% for liraglutide vs -1.21% for lixisenatide in adults with type 2 ...

Read more 
CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP GT technology

CEVEC and Généthon sign a collaboration agreement to develop lentiviral vector packaging cell lines based on CEVEC’s proprietary CAP GT technology

17 Sep 2015

Agreement enables fully scalable, industrial lentivirus vector production

Read more 
Impax receives FDA approval for generic version of Mestinon Timespan Tablets,     180 mg

Impax receives FDA approval for generic version of Mestinon Timespan Tablets, 180 mg

17 Sep 2015

First generic product approved from Hayward manufacturing facility following recent resolution of Warning Letter

Read more 
Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

Merck's omarigliptin achieved similar A1C reductions to Januvia in patients with type 2 diabetes inadequately controlled on Metformin monotherapy

17 Sep 2015

Omarigliptin was found to be non-inferior to Merck’s once-daily DPP-4 inhibitor, Januvia (sitagliptin), at reducing patients’ A1C levels from baseline, with similar A1C reductions achieved in both groups.

Read more 
Using proteomics to understand how genetic mutations rewire cancer cells

Using proteomics to understand how genetic mutations rewire cancer cells

17 Sep 2015

Scientific publications highlight studies using data from Thermo Scientific Orbitrap mass spectrometry and next-generation sequencing to discover how cancer attacks the protein networks controlling human cells

Read more 
Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria

Sandoz inaugurates BioInject — a new biopharmaceutical manufacturing facility in Schaftenau, Austria

17 Sep 2015

BioInject is a state-of-the-art facility that will be used to manufacture pre-filled syringes and devices for both Sandoz’s biosimilars and Novartis Pharma’s novel biologics.

Read more 
Technical knowledge alone is not enough for pharmaceutical professionals

Technical knowledge alone is not enough for pharmaceutical professionals

16 Sep 2015

Pharmaceutical professionals must develop wider commercial and business skills if they want to continue to secure the top jobs, according to NonStop Recruitment.

Read more 
Amgen to acquire privately-held Dezima Pharma

Amgen to acquire privately-held Dezima Pharma

16 Sep 2015

Dezima's lead molecule is TA-8995, an oral, once-daily cholesteryl ester transfer protein (CETP) inhibitor.

Read more